Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

LEXICON PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets

LEXICON PHARMACEUTICALS, INC. (LXRX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $128.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$191.00K, a 146.93% decline year-over-year.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $319.00K.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.08M.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $358.00K.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.53M.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$598.00K, a 120.63% decline from fiscal 2023.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $2.90M, a 817.41% increase from fiscal 2022.
  • LEXICON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $316.00K.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30-$191.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$128.00K
10-Q · filed 2026-08-06
-$956.00K
derived: sum of 3 quarters · filed 2026-08-06
-$598.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$319.00K
10-Q · filed 2026-05-07
-$765.00K
derived: sum of 2 quarters · filed 2026-05-07
-$407.00K
derived: sum of 3 quarters · filed 2026-05-07
$0.00
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$726.00K
derived: sum of 2 quarters · filed 2026-03-05
-$319.00K
derived: sum of 3 quarters · filed 2026-08-06
-$1.53M
10-K · filed 2026-03-05
2025-09-30$358.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$765.00K
derived: sum of 2 quarters · filed 2026-08-06
-$448.00K
10-Q · filed 2025-11-06
-$2.62M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$407.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$806.00K
10-Q · filed 2026-08-06
-$2.98M
derived: sum of 3 quarters · filed 2026-08-06
-$3.95M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$1.21M
10-Q · filed 2026-05-07
-$3.39M
derived: sum of 2 quarters · filed 2026-05-07
-$4.36M
derived: sum of 3 quarters · filed 2026-05-07
-$3.69M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$2.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$3.14M
derived: sum of 2 quarters · filed 2026-03-05
-$2.48M
derived: sum of 3 quarters · filed 2026-03-05
-$598.00K
10-K · filed 2026-03-05
2024-09-30-$969.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$303.00K
derived: sum of 2 quarters · filed 2025-11-06
$1.58M
10-Q · filed 2025-11-06
$2.54M
derived: sum of 4 quarters · filed 2026-03-05
2024-06-30$666.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$2.54M
10-Q · filed 2025-08-06
$3.51M
derived: sum of 3 quarters · filed 2026-03-05
$1.80M
derived: sum of 4 quarters · filed 2026-03-05
2024-03-31$1.88M
10-Q · filed 2025-05-14
$2.84M
derived: sum of 2 quarters · filed 2026-03-05
$1.14M
derived: sum of 3 quarters · filed 2026-03-05
$3.91M
derived: sum of 4 quarters · filed 2026-03-05
2023-12-31$964.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$744.00K
derived: sum of 2 quarters · filed 2026-03-05
$2.03M
derived: sum of 3 quarters · filed 2026-03-05
$2.90M
10-K · filed 2026-03-05
2023-09-30-$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$1.07M
derived: sum of 2 quarters · filed 2024-11-13
$1.94M
10-Q · filed 2024-11-13
$1.78M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30$2.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
$3.64M
10-Q · filed 2024-08-02
$3.49M
derived: sum of 3 quarters · filed 2025-03-07
$3.23M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31$867.00K
10-Q · filed 2024-05-02
$713.00K
derived: sum of 2 quarters · filed 2025-03-07
$451.00K
derived: sum of 3 quarters · filed 2025-03-07
$1.46M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31-$154.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
-$416.00K
derived: sum of 2 quarters · filed 2025-03-07
$589.00K
derived: sum of 3 quarters · filed 2025-03-07
$316.00K
10-K · filed 2025-03-07
2022-09-30-$262.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$743.00K
derived: sum of 2 quarters · filed 2023-11-08
$470.00K
10-Q · filed 2023-11-08
-$430.00K
derived: sum of 4 quarters · filed 2024-03-25
2022-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$732.00K
10-Q · filed 2023-08-04
-$168.00K
derived: sum of 3 quarters · filed 2024-03-25
-$1.70M
derived: sum of 4 quarters · filed 2024-03-25
2022-03-31-$273.00K
10-Q · filed 2023-05-04
-$1.17M
derived: sum of 2 quarters · filed 2024-03-25
-$2.71M
derived: sum of 3 quarters · filed 2024-03-25
-$2.06M
derived: sum of 4 quarters · filed 2024-03-25
2021-12-31-$900.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$2.43M
derived: sum of 2 quarters · filed 2024-03-25
-$1.79M
derived: sum of 3 quarters · filed 2024-03-25
-$2.88M
10-K · filed 2024-03-25
2021-09-30-$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$890.00K
derived: sum of 2 quarters · filed 2022-11-09
-$1.99M
10-Q · filed 2022-11-09
-$6.04M
derived: sum of 4 quarters · filed 2023-03-03
2021-06-30$644.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$451.00K
10-Q · filed 2022-08-03
-$4.51M
derived: sum of 3 quarters · filed 2023-03-03
-$2.64M
derived: sum of 4 quarters · filed 2023-03-03
2021-03-31-$1.09M
10-Q · filed 2022-05-05
-$5.16M
derived: sum of 2 quarters · filed 2023-03-03
-$3.29M
derived: sum of 3 quarters · filed 2023-03-03
-$2.02M
derived: sum of 4 quarters · filed 2023-03-03
2020-12-31-$4.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03
-$2.19M
derived: sum of 2 quarters · filed 2023-03-03
-$927.00K
derived: sum of 3 quarters · filed 2023-03-03
$1.95M
10-K · filed 2023-03-03
2020-09-30$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$3.13M
derived: sum of 2 quarters · filed 2021-11-09
$6.01M
10-Q · filed 2021-11-09
$5.36M
derived: sum of 4 quarters · filed 2022-03-10
2020-06-30$1.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$4.14M
10-Q · filed 2021-08-06
$3.49M
derived: sum of 3 quarters · filed 2022-03-10
$2.84M
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31$2.88M
10-Q · filed 2021-05-06
$2.22M
derived: sum of 2 quarters · filed 2022-03-10
$1.57M
derived: sum of 3 quarters · filed 2022-03-10
$3.51M
derived: sum of 4 quarters · filed 2022-03-10
2019-12-31-$653.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$1.30M
derived: sum of 2 quarters · filed 2022-03-10
$634.00K
derived: sum of 3 quarters · filed 2022-03-10
$2.65M
10-K · filed 2022-03-10
2019-09-30-$652.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30
$1.29M
derived: sum of 2 quarters · filed 2020-10-30
$3.31M
10-Q · filed 2020-10-30
$2.58M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$1.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$3.96M
10-Q · filed 2020-07-29
$3.23M
derived: sum of 3 quarters · filed 2021-03-12
$2.67M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$2.02M
10-Q · filed 2020-04-27
$1.29M
derived: sum of 2 quarters · filed 2021-03-12
$733.00K
derived: sum of 3 quarters · filed 2021-03-12
$402.00K
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31-$727.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$1.28M
derived: sum of 2 quarters · filed 2021-03-12
-$1.62M
derived: sum of 3 quarters · filed 2021-03-12
-$1.77M
10-K · filed 2021-03-12
2018-09-30-$558.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$889.00K
derived: sum of 2 quarters · filed 2019-11-07
-$1.04M
10-Q · filed 2019-11-07
-$1.06M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$331.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$481.00K
10-Q · filed 2019-08-01
-$504.00K
derived: sum of 3 quarters · filed 2020-03-12
-$6.22M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$150.00K
10-Q · filed 2019-05-01
-$173.00K
derived: sum of 2 quarters · filed 2020-03-12
-$5.89M
derived: sum of 3 quarters · filed 2020-03-12
-$6.09M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$5.74M
derived: sum of 2 quarters · filed 2020-03-12
-$5.94M
derived: sum of 3 quarters · filed 2020-03-12
$557.00K
10-K · filed 2020-03-12
-$557.00K
10-K · filed 2018-03-01
2017-09-30-$5.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
-$5.92M
derived: sum of 2 quarters · filed 2018-11-01
$580.00K
10-Q · filed 2018-11-01
$2.02M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$202.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30
$6.30M
10-Q · filed 2018-07-30
-$6.30M
10-Q · filed 2017-08-01
$7.73M
derived: sum of 3 quarters · filed 2019-03-15
-$1.03M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$6.50M
10-Q · filed 2018-05-03
-$6.50M
10-Q · filed 2017-05-04
$7.93M
derived: sum of 2 quarters · filed 2019-03-15
-$827.00K
derived: sum of 3 quarters · filed 2019-03-15
$4.37M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31$1.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$7.33M
derived: sum of 2 quarters · filed 2019-03-15
-$2.13M
derived: sum of 3 quarters · filed 2019-03-15
-$6.26M
10-K · filed 2019-03-15
$6.26M
10-K · filed 2017-03-06
2016-09-30-$8.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$3.56M
derived: sum of 2 quarters · filed 2017-11-08
-$7.69M
10-Q · filed 2017-11-08
$7.69M
10-Q · filed 2016-11-07
-$6.88M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$5.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$1.07M
10-Q · filed 2017-08-01
$1.88M
derived: sum of 3 quarters · filed 2018-03-01
-$1.92M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$4.13M
10-Q · filed 2017-05-04
-$3.32M
derived: sum of 2 quarters · filed 2018-03-01
-$7.12M
derived: sum of 3 quarters · filed 2018-03-01
-$11.08M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$816.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
-$2.99M
derived: sum of 2 quarters · filed 2018-03-01
-$6.94M
derived: sum of 3 quarters · filed 2018-03-01
-$5.37M
10-K · filed 2018-03-01
2015-09-30-$3.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
-$7.76M
derived: sum of 2 quarters · filed 2016-11-07
-$6.19M
10-Q · filed 2016-11-07
-$5.02M
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30-$3.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$2.39M
10-Q · filed 2016-08-04
-$1.21M
derived: sum of 3 quarters · filed 2017-03-06
$191.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$1.57M
10-Q · filed 2016-05-05
$2.74M
derived: sum of 2 quarters · filed 2017-03-06
$4.15M
derived: sum of 3 quarters · filed 2017-03-06
$3.38M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$2.58M
derived: sum of 2 quarters · filed 2017-03-06
$1.81M
derived: sum of 3 quarters · filed 2017-03-06
-$128.00K
10-K · filed 2017-03-06
2014-09-30$1.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$633.00K
derived: sum of 2 quarters · filed 2015-11-09
-$1.30M
10-Q · filed 2015-11-09
$1.32M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30-$772.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
-$2.71M
10-Q · filed 2015-08-07
-$85.00K
derived: sum of 3 quarters · filed 2016-03-11
-$658.00K
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31-$1.93M
10-Q · filed 2015-05-05
$687.00K
derived: sum of 2 quarters · filed 2016-03-11
$114.00K
derived: sum of 3 quarters · filed 2016-03-11
$1.87M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$2.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$2.05M
derived: sum of 2 quarters · filed 2016-03-11
$3.80M
derived: sum of 3 quarters · filed 2016-03-11
$1.71M
10-K · filed 2016-03-11
2013-09-30-$573.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$1.18M
derived: sum of 2 quarters · filed 2014-11-06
-$908.00K
10-Q · filed 2014-11-06
$1.75M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$1.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$335.00K
10-Q · filed 2014-08-07
$2.32M
derived: sum of 3 quarters · filed 2015-03-12
-$102.00K
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31-$2.09M
10-Q · filed 2014-05-08
$566.00K
derived: sum of 2 quarters · filed 2015-03-12
-$1.86M
derived: sum of 3 quarters · filed 2015-03-12
-$3.29M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$2.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$233.00K
derived: sum of 2 quarters · filed 2015-03-12
-$1.21M
derived: sum of 3 quarters · filed 2015-03-12
-$2.60M
10-K · filed 2015-03-12
2012-09-30-$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$3.86M
derived: sum of 2 quarters · filed 2013-11-12
-$5.26M
10-Q · filed 2013-11-12
-$4.67M
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30-$1.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
-$2.83M
10-Q · filed 2013-08-01
-$2.25M
derived: sum of 3 quarters · filed 2014-03-07
-$2.71M
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31-$1.40M
10-Q · filed 2013-05-10
-$806.00K
derived: sum of 2 quarters · filed 2014-03-07
-$1.27M
derived: sum of 3 quarters · filed 2014-03-07
-$1.70M
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31$589.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
$126.00K
derived: sum of 2 quarters · filed 2014-03-07
-$300.00K
derived: sum of 3 quarters · filed 2014-03-07
-$865.00K
10-K · filed 2014-03-07
2011-09-30-$463.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
-$889.00K
derived: sum of 2 quarters · filed 2012-11-07
-$1.45M
10-Q · filed 2012-11-07
-$1.08M
derived: sum of 4 quarters · filed 2013-03-11
2011-06-30-$426.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$991.00K
10-Q · filed 2012-08-02
-$615.00K
derived: sum of 3 quarters · filed 2013-03-11
$2.66M
derived: sum of 4 quarters · filed 2013-03-11
2011-03-31-$565.00K
10-Q · filed 2012-05-03
-$189.00K
derived: sum of 2 quarters · filed 2013-03-11
$3.09M
derived: sum of 3 quarters · filed 2013-03-11
2010-12-31$376.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$3.65M
derived: sum of 2 quarters · filed 2013-03-11
$6.70M
10-K · filed 2013-03-11
2010-09-30$3.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01
$6.33M
10-Q · filed 2011-11-01
2010-06-30$3.05M
10-Q · filed 2011-08-09
2009-12-31-$869.00K
10-K · filed 2012-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78